Recombinant Mycobacterium Tuberculosis Fusion Protein(D-EC)
重组结核杆菌融合蛋白（D-EC）
Report date: 2026/05/15 20:01:45
Base Information
Drug NameRecombinant Mycobacterium Tuberculosis Fusion Protein(D-EC)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesKangzhong (Beijing)Biotechnology Co LtdKangwei Zhonghe (Zhongshan) Biological Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesKangzhong (Beijing)Biotechnology Co LtdKangwei Zhonghe (Zhongshan) Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A